Drawing for HEPATOTECH

USPTO serial 78165834

HEPATOTECH

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BERK, STEVEN R
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with HEPATOTECH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Wei Wei Jeang

WEI WEI JEANG MUNSCH HARDT KOPF & HARR, PC4000 FOUNTAIN PL1445 ROSS AVEDALLAS, TX 75202-2790

Goods and services

ClassDescriptionStatusFirst use
001bio chemicals, namely, enzymes, monoclonal antibodies and fragments thereof for use in the manufacture of medicine in the field of pharmaceutical and biological research and development and for clinical diagnostic and therapeutic use for the treatment of diseases; manufactured cell for scientific, laboratory or medical research, namely plated, cultured, and suspension hepatocytes; manufactured cell kits for specific, laboratory or medical research, comprised of live hepatic cells and culture media shipping purposes; manufactured cells for scientific, laboratory or medical research, namely cells lines for pharmaceutical and biological research and development and for clinical diagnostic and therapeutic use for the treatment of diseasesACTIVE—
042providing manufactured cell and cell products to others; providing product development consultation regarding pharmaceutical and biological products; and providing laboratory research testing services in the field of metabolism and enzyme inductionACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jun 29, 2004ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 21, 2003GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 6, 2003CFITCASE FILE IN TICRS—
Aug 25, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 25, 2003MAILPAPER RECEIVED—
Feb 25, 2003GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 10, 2003DOCKASSIGNED TO EXAMINER—
Feb 10, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance